Plus Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.99 Insider Own0.20% Shs Outstand21.51M Perf Week-1.76%
Market Cap11.09M Forward P/E- EPS next Y-0.72 Insider Trans- Shs Float20.60M Perf Month-24.87%
Income-14.80M PEG- EPS next Q-0.19 Inst Own14.70% Short Float0.24% Perf Quarter-48.51%
Sales- P/S- EPS this Y40.40% Inst Trans73.82% Short Ratio0.27 Perf Half Y-64.38%
Book/sh0.68 P/B0.76 EPS next Y-3.90% ROA-64.30% Target Price5.17 Perf Year-76.99%
Cash/sh0.99 P/C0.52 EPS next 5Y- ROE-113.40% 52W Range0.41 - 2.95 Perf YTD-50.48%
Dividend- P/FCF- EPS past 5Y71.90% ROI- 52W High-82.37% Beta0.47
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low26.77% ATR0.07
Employees14 Current Ratio4.50 Sales Q/Q- Oper. Margin- RSI (14)31.74 Volatility14.37% 12.10%
OptionableNo Debt/Eq0.43 EPS Q/Q41.80% Profit Margin- Rel Volume0.19 Prev Close0.52
ShortableYes LT Debt/Eq0.32 EarningsApr 21 AMC Payout- Avg Volume178.72K Price0.52
Recom- SMA20-9.42% SMA50-35.19% SMA200-60.20% Volume33,124 Change0.00%
Jan-25-21Initiated Ladenburg Thalmann Buy $8
Oct-16-20Initiated Maxim Group Buy $6
May-18-22 07:00AM  
Apr-26-22 07:00AM  
Apr-21-22 04:05PM  
Apr-19-22 07:00AM  
Apr-14-22 07:00AM  
Apr-08-22 04:05PM  
Apr-05-22 07:00AM  
Mar-23-22 07:00AM  
Mar-22-22 07:00AM  
Mar-03-22 07:30AM  
Feb-24-22 04:05PM  
Feb-22-22 07:00AM  
Feb-18-22 07:00AM  
Feb-07-22 07:00AM  
Jan-14-22 07:41AM  
Jan-07-22 07:00AM  
Jan-06-22 07:00AM  
Jan-04-22 07:53AM  
Dec-02-21 07:30AM  
Nov-22-21 07:31AM  
Nov-18-21 02:18PM  
Nov-12-21 07:30AM  
Nov-09-21 07:00AM  
Nov-03-21 07:00AM  
Oct-29-21 10:04AM  
Oct-27-21 02:00PM  
Oct-21-21 04:05PM  
Oct-19-21 07:30AM  
Oct-14-21 07:30AM  
Sep-30-21 08:00AM  
Sep-27-21 07:30AM  
Sep-23-21 07:30AM  
Sep-13-21 07:00AM  
Sep-08-21 07:00AM  
Sep-02-21 07:00AM  
Aug-23-21 06:25AM  
Aug-21-21 09:24AM  
Aug-19-21 08:13AM  
Aug-13-21 07:51AM  
Aug-11-21 10:12AM  
Aug-05-21 07:30AM  
Jul-27-21 07:00AM  
Jul-22-21 04:05PM  
Jul-15-21 07:30AM  
Jun-16-21 07:30AM  
Jun-10-21 07:30AM  
Jun-09-21 04:15PM  
May-24-21 06:46AM  
May-04-21 07:30AM  
Apr-22-21 04:05PM  
Apr-08-21 07:30AM  
Mar-23-21 07:30AM  
Mar-18-21 08:30AM  
Mar-05-21 11:51AM  
Mar-04-21 11:04AM  
Mar-03-21 07:30AM  
Mar-02-21 07:30AM  
Mar-01-21 07:30AM  
Feb-22-21 04:05PM  
Feb-11-21 04:15PM  
Jan-11-21 10:11AM  
Jan-05-21 04:15PM  
Dec-15-20 07:30AM  
Dec-08-20 07:30AM  
Dec-01-20 07:30AM  
Nov-19-20 08:00AM  
Nov-16-20 08:00AM  
Nov-13-20 07:30AM  
Nov-12-20 07:25AM  
Nov-05-20 07:00AM  
Oct-29-20 07:00AM  
Oct-22-20 04:05PM  
Oct-15-20 07:00AM  
Oct-14-20 04:15PM  
Oct-02-20 07:00AM  
Oct-01-20 07:00AM  
Sep-15-20 07:00AM  
Sep-09-20 07:00PM  
Sep-03-20 07:00AM  
Sep-01-20 07:00AM  
Aug-28-20 07:00AM  
Aug-25-20 10:31AM  
Aug-10-20 07:43AM  
Aug-03-20 07:00AM  
Jul-28-20 07:00AM  
Jul-23-20 05:00PM  
Jul-06-20 08:01AM  
May-14-20 04:27PM  
May-12-20 08:57AM  
May-11-20 06:00AM  
May-07-20 04:15PM  
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Petersen GregDirectorMay 17Buy0.5530,00016,50062,500May 19 04:15 PM
HEDRICK MARC HChief Executive OfficerApr 26Buy0.682,5001,71028,580Apr 28 07:00 AM
HEDRICK MARC HChief Executive OfficerApr 26Buy0.695,0003,45026,080Apr 27 07:00 AM
Sims Andrew John Hugh MacIntyrChief Financial OfficerApr 26Buy0.673,0002,01612,230Apr 27 07:00 AM
Sims Andrew John Hugh MacIntyrChief Financial OfficerMar 01Buy1.102,0002,2009,230Mar 03 06:15 AM
Sims Andrew John Hugh MacIntyrChief Financial OfficerNov 02Buy1.861,0001,8647,230Nov 04 06:15 AM
Petersen GregDirectorOct 27Buy1.7212,50021,50032,500Oct 28 06:15 AM
HEDRICK MARC HChief Executive OfficerOct 26Buy1.662,5004,15021,080Oct 27 06:15 AM
Sims Andrew John Hugh MacIntyrChief Financial OfficerOct 26Buy1.672,0003,3396,230Oct 27 06:15 AM
Lenk Robert PDirectorSep 13Buy1.867,00013,01110,000Sep 15 07:30 AM
Sims Andrew John Hugh MacIntyrChief Financial OfficerJul 28Buy1.912,2444,2864,230Jul 29 06:35 PM
Sims Andrew John Hugh MacIntyrChief Financial OfficerJul 27Buy2.051,9864,0711,986Jul 29 06:35 PM